Table of Content
Hormonal birth control can change sex drive, but not for everyone, and research disagrees about how often. The clearest physical mechanism involves a protein called SHBG.
Here is a number that surprises people. In a 2026 study in the Journal of Sex & Marital Therapy, 241 female medical students completed the Female Sexual Function Index, and 47.6% met the cutoff for sexual dysfunction. Women using hormonal contraception scored better than those using non-hormonal methods or no contraception at all.
That result runs against what most people expect, and it is exactly why this question is hard to answer with a yes or a no. The physiology is real and measurable. The effect on desire is inconsistent between people and between studies, and both of those statements can be true at once.
Did Birth Control Lower My Sex Drive?
It might have, and it might not be the only thing involved. The honest answer is that timing is suggestive but not proof, and the only way to narrow it down is to look at everything that changed around the same time.
Desire does not run on one switch. Mayo Clinic describes it as a mix of physical and emotional well-being, past experiences, beliefs, lifestyle and the current relationship, and notes there is no magic number that defines a low sex drive.
That list is worth taking seriously before pinning everything on a method. Pain during sex, fatigue, stress, alcohol, smoking, thyroid or blood sugar problems, and some prescription medicines can all pull desire down. Many of the things that commonly kill libido have nothing to do with contraception.
Still, if desire dropped within a few months of starting a method and nothing else changed, that pattern is worth raising. It is information, not a diagnosis, and it belongs in the conversation rather than in a search bar.
What Does SHBG Have to Do With It?
SHBG is the mechanism people are reaching for when they say the pill lowered their testosterone. It stands for sex hormone binding globulin, and it decides how much of your sex hormones are actually available to your body.
MedlinePlus explains that SHBG is a protein made mostly in the liver that binds to sex hormones such as testosterone and estrogen and helps control how much of them stay active. Hormones bound to SHBG cannot work with your tissues. Only the free ones can.
The link to contraception is specific. MedlinePlus lists use of estrogen-containing medicines, such as birth control pills or hormone therapy for menopause, among the things related to high SHBG levels in women. And when SHBG is high, less of the total testosterone is available for the tissues to use.
Testosterone matters here even though it is often called a male hormone. MedlinePlus notes it is present in females in smaller amounts and that in both sexes it helps control sex drive. So a route from an estrogen-containing method to less available testosterone to lower desire is physiologically coherent.
Why Total Testosterone Can Look Normal
This is the part that causes the most frustration in appointments. A total testosterone test measures free testosterone and testosterone attached to proteins together, and it cannot tell the two apart. One number arrives, and it hides the only figure that matters here.
MedlinePlus states the consequence plainly: you could have symptoms from too little or too much free testosterone even when your total testosterone level is normal. An SHBG result alongside the total is what lets a clinician estimate the free portion.
So a normal lab printout does not close the question, and it is reasonable to ask which tests were actually run. Hormone questions of this kind sit with endocrinology, and a clinician such as Irina Urusova, MD works on exactly this sort of hormonal picture rather than on contraception choice alone.
Why Does the Research Disagree?
Because sexual function is measured through questionnaires, in different populations, with people who chose their own methods rather than being assigned one. The 2026 Journal of Sex & Marital Therapy authors say it directly: evidence remains heterogeneous across studies, and they call for more research.
In their own data, intrauterine device use was independently associated with lower odds of sexual dysfunction, which they describe as a potential protective role rather than a proven one. A single cross-sectional study of medical students in Brazil cannot settle the question for everyone.
There is also a selection problem that is easy to miss. People who feel worse on a method tend to stop using it, so the people still using it at the time of a survey are disproportionately the ones it suits. That alone can push group averages in a favorable direction.
None of this means individual reports are wrong. It means population research and personal experience are answering slightly different questions. A study average describes a group; it cannot tell you what happened in your own body, and it was never designed to.
Does the Method Matter – Pill, IUD, Implant or Copper?
Yes, at least in terms of what the hormone is and where it acts. The documented SHBG route involves estrogen-containing methods, and not every method contains estrogen. That single difference is why switching method type is a reasonable thing to discuss.
Estrogen-Containing Methods
ACOG describes the combined pill, the patch and the vaginal ring as combined hormonal methods containing estrogen and progestin, released into the whole body. That whole-body exposure is the part that connects to the SHBG finding.
ACOG's list of possible side effects for the combined pill names headache, nausea, breast tenderness and breakthrough bleeding, and notes that most side effects are minor and often go away after a few months of use. Desire is not on that list. That absence is part of why women who raise it feel unheard, even by clinicians who are reading the standard guidance correctly.
Progestin-Only and Local Methods
The hormonal IUD works differently. ACOG explains that it releases progestin into the uterus, with brands approved for three to eight years, while the implant releases a hormone from a small rod under the skin of the upper arm.
Reported side effects differ too. For the hormonal IUD, ACOG lists bleeding changes, headaches, nausea, breast tenderness and mood changes. For the implant, it lists unpredictable bleeding, digestive difficulties, headaches, breast pain, weight gain and acne. Mood appears on one list and not the other, which is worth noticing.
Non-Hormonal Options
The copper IUD contains no hormones at all. ACOG notes that it releases copper into the uterus, is approved for up to 10 years of use, and that painful periods and heavier bleeding may increase during the first months, with over-the-counter pain relief an option for that stretch.
That makes it the method with no hormonal route to SHBG at all, which is why it comes up so often in these conversations. Barrier methods and fertility awareness sit outside the hormonal question entirely too, though they differ sharply from an IUD in how much they depend on consistent use.
What Each Method Type Involves
The table pulls the four groups together on the points that matter for this question. It is a summary of what the sources above document, not a ranking, and the right method depends on far more than desire.
|
Method type |
Hormones involved |
Side effects the source lists |
Documented SHBG link |
|---|---|---|---|
|
Combined pill, patch, ring |
Estrogen and progestin, released into the whole body |
Headache, nausea, breast tenderness, breakthrough bleeding; most minor and often fading after a few months |
MedlinePlus lists estrogen-containing medicines, including birth control pills, among causes of high SHBG in women |
|
Hormonal IUD |
Progestin, released into the uterus |
Bleeding changes, headaches, nausea, breast tenderness, mood changes |
Not among the estrogen-containing medicines MedlinePlus links to high SHBG |
|
Implant |
A hormone released from a rod under the skin of the upper arm |
Unpredictable bleeding, digestive difficulties, headaches, breast pain, weight gain, acne |
Not among the estrogen-containing medicines MedlinePlus links to high SHBG |
|
Copper IUD |
None; releases copper |
Painful periods and heavier bleeding may increase in the first months |
No hormonal route to SHBG |
What About Dryness and Pain Rather Than Desire?
Dryness and low desire are separate problems that often arrive together, and mixing them up makes both harder to solve. One is about tissue and lubrication. The other is about wanting sex in the first place. They need different examinations and different conversations.
The order matters because pain feeds back into desire. Mayo Clinic lists pain during sex and difficulty reaching orgasm among the physical causes of low sex drive, which means a tissue problem left unaddressed can look like a desire problem months later.
Estrogen levels are the usual explanation when dryness shows up around midlife rather than on a contraceptive method. The pattern seen in painful sex and vaginal dryness is worth comparing against your own timeline, since the fix is different from anything involving contraception.
If penetration has become uncomfortable, say that out loud at the appointment rather than describing it as low libido. It changes which examination happens and which questions get asked next, and it moves the visit away from a conversation about motivation and toward one about the body.
If I Stop, Will My Sex Drive Come Back?
Nobody can promise a timeline, and no reliable source gives one. What is documented is narrower than what people want to hear: these methods are reversible, and the hormonal mechanism described above is tied to taking the medicine rather than to having taken it.
ACOG states that long-acting methods are reversible and can be removed at any time if you want to get pregnant or simply want to stop. For the combined pill, ACOG notes that most side effects are minor and often resolve after a few months of use, which is a statement about adjusting rather than about stopping.
On the SHBG side, MedlinePlus frames high levels as related to the use of estrogen-containing medicines. That wording ties the effect to current use, but it is not the same as a study measuring how quickly desire returns afterward, and that study is not something to pretend exists.
What usually happens in practice is slower and less tidy than the internet suggests. Other causes from Mayo's list may still be in play after a method is stopped, which is why some people feel no difference and conclude the method was never the issue.
My Doctor Said It Is in My Head – Is It Physiology?
Both can be true, and neither makes the experience less real. Mayo Clinic's own account of low desire includes physical causes, hormone changes, psychological causes and relationship factors in the same breath, without ranking one above the others.
The dismissal usually comes from a mismatch rather than from disbelief. Desire is not measurable on a blood panel, the common patient-education lists do not name it as a side effect, and a normal total testosterone looks reassuring on a screen even when it leaves the free portion unknown.
Which is why specifics work better than labels in the appointment. A date when it changed, a method start date, what else was going on that month, and whether arousal, lubrication, orgasm or desire is the part that shifted all give a clinician something to work with.
If a conversation keeps stalling, asking for the SHBG and total testosterone together is a concrete request rather than an argument. A clinician who makes house calls can also order that panel and take the history without a rushed fifteen-minute slot.
How Common Is This, and Who Else Reports It?
Common enough that researchers now study the belief itself, not only the biology. Hormone concerns are driving method choices across a whole age group, and the pattern is strong enough that it has its own name in the literature.
A 2026 study in Contraception interviewed 40 young adults using hormonal or non-hormonal long-acting methods between January and June 2025. Most expressed hesitancy about hormones, and participants attributed undesired changes in their menstruation or libido to those hormones.
The same work describes two other threads: a sense that hormonal contraception diverges from a natural lifestyle, reinforced by anti-hormonal social media content, and a preference for non-hormonal options such as the copper IUD, fertility awareness methods and condoms.
The authors' conclusion is not that the concerns are imaginary. It is that young adults need medically accurate information about hormones so they can weigh evidence against their own preferences, which is a fair summary of what this whole topic needs.
What to Bring to the Appointment
Specific observations, in writing, beat a general complaint every time. Five lines in a note on your phone are enough to change the shape of the visit, because they give the clinician a timeline instead of an impression.
The date you started the method, and the month you first noticed a change
Which part changed: desire, arousal, lubrication, orgasm or comfort
Anything else that shifted in the same window, including stress, sleep, alcohol, new prescriptions or relationship changes
Whether the change is constant or comes and goes with your cycle
What you want from the visit: lab work, a method change, or a referral
Lab work is one route and talking therapy is another, and the two are not in competition. Some of this work sits with body-based practitioners rather than with prescribers, and Sex and Sensibility does somatic sex education and intimacy coaching for people navigating low desire, arousal changes and pelvic discomfort.
Knowing who does what saves months of wrong appointments. The differences between a sex therapist, a sexologist and a somatic educator are worth reading before booking, because the title determines what that person is trained and licensed to address.
If desire has changed for reasons that have nothing to do with contraception, that is worth knowing too, and it is a common outcome of asking the question properly. Age-related hormonal shifts follow their own pattern, and what changes in perimenopause looks different from a method-related timeline.
FAQ
-
No special preparation is needed for the test itself. MedlinePlus advises telling your provider about all medicines, vitamins and supplements you take, since hormone-containing medicines can affect SHBG levels, and says not to stop any medicine unless your provider tells you to.
-
No. ACOG states that the IUD and the implant do not protect against sexually transmitted infections, including HIV, and recommends a condom for protection if you are at risk. Protection against infection and protection against pregnancy are separate jobs.
-
ACOG reports that with typical use of combined hormonal methods, 9 in 100 women become pregnant in the first year, and with perfect use fewer than 1 in 100. For the IUD and implant, fewer than 1 in 100 become pregnant in the first year, making them about 20 times more effective than pills, the patch or the ring.
-
Sometimes. ACOG notes that hormonal IUDs may cause frequent spotting and heavier bleeding in the first months, after which the amount of bleeding usually decreases and period pain usually eases, and that in some cases menstrual bleeding stops completely.
-
Several. ACOG lists more regular, lighter and shorter periods, reduced menstrual cramps, a lower risk of cancer of the uterus, ovary and colon, and possible improvement in acne and unwanted hair growth, along with uses for heavy bleeding and menstrual pain.
-
It can be. Mayo Clinic notes that when a lack of interest in sex continues or returns and causes personal distress, it may be a treatable condition called sexual interest-arousal disorder, and adds that you do not have to meet that medical definition to ask for help.
Sources Used
Assessing Sexual Dysfunction in Female Medical Students: The Role of Contraceptive Methods – Journal of Sex & Marital Therapy, via PubMed (2026)
Combined Hormonal Birth Control: Pill, Patch, and Ring – American College of Obstetricians and Gynecologists (2025)
Hormone Hesitancy: Young Adults' Experiences with Long-Acting Reversible Contraceptives – Contraception, via PubMed (2026)
Long-Acting Reversible Contraception (LARC): Intrauterine Device (IUD) and Implant – American College of Obstetricians and Gynecologists (2026)
Low sex drive in women – Mayo Clinic (2024)
SHBG Blood Test – MedlinePlus, National Library of Medicine (2026)
Written by Sofiia Puhach
November 4, 2026
You May Also Like
E. coli lives in the bowel; UTIs start when it travels the short distance to the urethra and multiplies.